1 Min Read
May 30 (Reuters) - Spectral Medical Inc:
* Spectral Medical- submitted fourth and final module of its PMA application to U.S. FDA based on further analysis of euphrates trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.